Stockreport

Alpha Tau Announces Full Year 2024 Financial Results and Provides Corporate Update

Alpha Tau Medical Ltd. - Ordinary Shares  (DRTS) 
PDF - Interim results from three trials exploring the use of Alpha DaRT® in treating pancreatic cancer showing high disease control rate, impressive overall survival in sub- [Read more]